A physician’s perspective on health equity, diversity and inclusion
PharmaVoice
APRIL 24, 2023
Dr. Preeti Parikh sees parallels between promoting health equity and current DE&I challenges in the workplace.
Sat.Apr 22, 2023 - Fri.Apr 28, 2023
98 
What Will it Take for the U.S. to Modernize its Public Health Systems?
PM360
APRIL 25, 2023
How can countries be better prepared for the next pandemic? How do they need to change their public health infrastructure to ensure they don’t face similar challenges as posed by COVID-19? What can countries learn from each other to get these more modernized systems in place to improve their ability to exchange public health data across the globe? These questions were at the heart of many discussions during the 2023 Healthcare Information Management System Society (HIMSS) Global Health Conferen
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Apellis hits setback in ALS trial after pair of pegcetacoplan approvals
Fierce Pharma
APRIL 24, 2023
Apellis hits setback in ALS trial after pair of pegcetacoplan approvals fkansteiner Mon, 04/24/2023 - 10:56
Healthcare Leaders Must Come Together to Mitigate ChatGPT Risks, Experts Urge
MedCity News
APRIL 23, 2023
The healthcare sector has been notoriously slow to adopt new technologies in the past, but Chat-GPT has already begun to enter the field. Technology experts at the HIMSS conference in Chicago said that while the AI model is certainly exciting, the healthcare sector must establish an accountability framework for it’s going to address the risks of new technologies like ChatGPT moving forward.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Breathing easy: How digital inhalers are changing asthma treatment
Pharmaceutical Technology
APRIL 26, 2023
AstraZeneca , Teva Pharmaceuticals , and Novartis , and other companies, are expanding their reach in the asthma space by capitalizing on digital technologies to enhance the patient experience. But experts say the complete integration of these devices and platforms into the healthcare system remains to be seen. Dr. Amy Chan, senior clinical research fellow at the School of Pharmacy, University of Auckland, says digital inhalers have existed for almost 30 years.
Pioneering malaria vaccine gains regulatory clearance
European Pharmaceutical Review
APRIL 25, 2023
The R21/Matrix-M malaria vaccine, developed by the University of Oxford , has been approved for use in Ghana (13 April 2023) and was authorised for use in Nigeria on 17 April. [Regulatory] approval of the [R21/Matrix-M ] malaria vaccine in Ghana was the first in the world” Approval of the malaria vaccine in Ghana was the first in the world. Granted full national licensure by the country’s Food and Drugs Authority (FDA Ghana), it is authorised for children aged 5 to 36 months.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Report: Firearm-related Injuries Cost US Healthcare $1B Annually
MedCity News
APRIL 25, 2023
In just 2020, deaths from gun violence cost the U.S. healthcare system $290 million, or about $6,400 per patient, according to a report from the Commonwealth Fund. These costs are mostly covered by Medicaid and other government insurance programs.
Discussing Sterile Aseptic Connectors with Todd Andrews (INTERPHEX 2023)
PharmaTech
APRIL 28, 2023
Todd Andrews, global director of Applications and Business Development at CPC, discusses sterile aseptic connectors, flexibility in manufacturing, and more in an interview held at INTERPHEX 2023.
Immunotherapy to become standard treatment for infants with ALL
European Pharmaceutical Review
APRIL 27, 2023
Immunotherapy treatment blinatumomab will now become standard treatment worldwide for babies with acute lymphoblastic leukaemia (ALL). This decision is based on new results from an international trial published in the New England Journal of Medicine. Blinatumomab significantly improved survival, with the rate increasing from 66 percent to 93 percent, compared to individuals just given prior chemotherapy.
FDA approves first oral microbiome therapy Vowst. Will Nestlé be around to help Seres with the launch?
Fierce Pharma
APRIL 26, 2023
FDA approves first oral microbiome therapy Vowst. Will Nestlé be around to help Seres with the launch?
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Reading Between the Lines of the DEA’s Proposed Rules on Telemedicine
MedCity News
APRIL 28, 2023
In some ways, the Drug Enforcement Agency’s (DEA) proposed rules for prescribing controlled substances via telemedicine are a sign of progress.
Editas grabs orphan drug status for sickle cell disease CRISPR therapy
Pharmaceutical Technology
APRIL 28, 2023
The US Food and Drug Administration (FDA) has granted an Orphan Drug Designation to Editas Medicine’s gene therapy EDIT-301 in sickle cell disease, based on an April 27 announcement. The US agency previously granted the Orphan Drug Designation to EDIT-301 for its study in beta thalassemia, in May 2022. The company is studying EDT-301 in sickle cell disease in a Phase I/II RUBY study (NCT04853576), and is on track to provide a clinical update by mid-2023.
Roy Vagelos is retiring and leaving a legacy of leadership lessons
PharmaVoice
APRIL 25, 2023
The longtime pharma leader is stepping down from his role as chair of Regeneron’s board in June after decades in drug development.
After IRA, lawmakers look for more ways to cut drug prices
Fierce Pharma
APRIL 26, 2023
After IRA, lawmakers look for more ways to cut drug prices kdunleavy Wed, 04/26/2023 - 13:38
In Which Areas of Healthcare Do Investors Want More Startup Activity?
MedCity News
APRIL 27, 2023
While the digital health sector might feel a little cramped in some areas, there are wide open spaces in others — and investors are ready to funnel money into companies looking to innovate these lesser-discussed aspects of care delivery and healthcare technology. Some of these areas include Medicaid, generative AI and patient-to-patient support.
Exploring the impact of globalization on research in the United States
Clarivate
APRIL 27, 2023
Our latest Global Research Report from the Institute for Scientific Information (ISI) , “U.S. research trends: The impact of globalization and collaboration,” raises important questions about how well past investment has prepared the U.S. scientific enterprise to achieve its goals. Our findings suggest that while the U.S. remains a leading science and technology power, it must acknowledge its shrinking domestic research capacity and work collaboratively with resourceful competitors to maintain i
EC announces EU pharma reform that cuts market exclusivity
Pharmaceutical Technology
APRIL 27, 2023
The European Commission’s (EC) long-anticipated pharma reform plans in the European Union have finally been unveiled , indicating a focus on improving access to medicines across the bloc while cutting down on market exclusivity. Described as the largest reform in over 20 years, the proposed revision touches on multiple topics ranging from unequal access to innovative medicines across the EU to new environmental protections.
Bristol Myers' Giovanni Caforio to hand CEO baton to commercial chief Chris Boerner
Fierce Pharma
APRIL 26, 2023
Bristol Myers' Giovanni Caforio to hand CEO baton to commercial chief Chris Boerner esagonowsky Wed, 04/26/2023 - 16:44
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Achieve Precision Medicine Through AI and Analytics Solutions [Sponsored]
MedCity News
APRIL 25, 2023
MedCity News connected with Integra Connect’s COO, Cory Wiegert at ViVE 2023 to discuss how their new platform will go beyond the “one size fits all” approach to data curation.
European Pharmaceutical Review Issue 2 2023
European Pharmaceutical Review
APRIL 24, 2023
Included in this issue of European Pharmaceutical Review : FOREWORD New quality requirements for tobacco products David Elder, David P Elder Consultancy QA/QC MASS SPECTROMETRY The benefits of mass spectrometry for expediting biologics to patients Ian Anderson, Mostafa Zarei and Qifeng Zhang, Lonza IN-DEPTH FOCUS: Bioprocessing/Bioproduction Realising the potential of AAV gene therapies Rajiv Vaidya, Andelyn Biosciences What gene therapy manufacturers can gain from collaboration Neil Almstead,
Ethnopharmacology: traditional medicine and modern drug discovery
Pharmaceutical Technology
APRIL 24, 2023
Traditional medicine refers to the knowledge, skills and practices that indigenous and different cultures use to maintain health, encompassing forms such as herbal medicine, Traditional Chinese Medicine (TCM) and acupuncture. While 80% of the world’s population practices some form of traditional medicine, according to the World Health Organization (WHO), the practice is regularly discredited due to a lack of scientific support and regulation as well as evidence of negative side effects with cert
Bristol's multiple new launches won't stop it from scouting for M&A deals, CEO says
Fierce Pharma
APRIL 27, 2023
Bristol's multiple new launches won't stop it from scouting for M&A deals, CEO says aliu Thu, 04/27/2023 - 10:16
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Kaiser Permanente to Acquire Geisinger, Along with 5-6 More Health Systems in the Near Future
MedCity News
APRIL 26, 2023
Kaiser Permanente announced that it expects to acquire Pennsylvania-based Geisinger Health. Kaiser’s move is part of a larger plan — Geisinger will be the first health system to join Risant Health, a new company Kaiser launched to operate nonprofit health systems under value-based care models. Kaiser said it expects to invest $5 billion in Risant and fold five or six health systems into the company over the next five years.
Guide To Testing
European Pharmaceutical Review
APRIL 24, 2023
Included in this Guide to Testing: Exploring low endotoxin recovery in drug products Chiara Celli, Marco Mingolla and Fabrizio Lecce from the Institute of Biomedical Research Antoine Marxer, discuss low endotoxin recovery in drug products analysed using the monocyte activation test. Sustainability in BET from your endotoxin experts Associates of Cape Cod International, Inc. explores the future of sustainable LAL testing.
5 minutes with — DTRA’s Dr. Amir Kalali
PharmaVoice
APRIL 28, 2023
An industry veteran, innovator and curator, Dr. Amir Kalali’s vision for the future is patient-focused.
UPDATED: Gearing up for key approvals, GSK projects 'Shingrix-like' sales for its RSV vaccine
Fierce Pharma
APRIL 26, 2023
UPDATED: Gearing up for key approvals, GSK projects 'Shingrix-like' sales for its RSV vaccine fkansteiner Wed, 04/26/2023 - 09:52
How to Stay Competitive in the Evolving State of Martech
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
With Halo Shutdown, Amazon Has Now Closed 3 of Its Healthcare Divisions Since 2021
MedCity News
APRIL 28, 2023
Amazon recently announced that it is shuttering its Halo division, a line of wearable health and fitness devices. This marks the third time in about two years that the e-commerce giant has closed one its healthcare businesses — Amazon Care failed last year, and Haven failed in 2021.
Innovating pharma at the edge
European Pharmaceutical Review
APRIL 28, 2023
NEW, FLEXIBLE, data-driven manufacturing models are emerging to address the pharmaceutical industry’s need for greater operational efficiency. While new approaches aim to solve the unique challenges of the sector, like adhering to strict compliance regulations, digitalisation has quickly developed into a pathway for achieving information technology (IT)/operational technology (OT) integration, edge-to-enterprise connectivity, and overall operational excellence.
PCC 2023: ESG, New Turf for Compliance
PharmExec
APRIL 27, 2023
While ESG is still in the early stages for pharma, many companies are moving forward with a need for compliance.
EU plots major pharma reforms—but industry is already pushing back
Fierce Pharma
APRIL 28, 2023
EU plots major pharma reforms—but industry is already pushing back zbecker Fri, 04/28/2023 - 18:04
Let's personalize your content